C, L., T, A., & PB, D. (2015). The impact on health outcome measures of switching to generic medicines consequent to reference pricing: The case of olanzapine in New Zealand. Journal of primary health care, 7(2), 94.
Chicago Style (17th ed.) CitationC, Lessing, Ashton T, and Davis PB. "The Impact on Health Outcome Measures of Switching to Generic Medicines Consequent to Reference Pricing: The Case of Olanzapine in New Zealand." Journal of Primary Health Care 7, no. 2 (2015): 94.
MLA (9th ed.) CitationC, Lessing, et al. "The Impact on Health Outcome Measures of Switching to Generic Medicines Consequent to Reference Pricing: The Case of Olanzapine in New Zealand." Journal of Primary Health Care, vol. 7, no. 2, 2015, p. 94.
Warning: These citations may not always be 100% accurate.